Research suggests interrupting immune response improves multiple sclerosis outcomes

Journal Reference: Kelly L. Monaghan, Drake Aesoph, Amanda G. Ammer, Wen Zheng, Shokofeh Rahimpour, Breanne Y. Farris, Camille A. Spinner, Peng Li, Jian-Xin Lin, Zu-Xi Yu, Vanja Lazarevic, Gangqing Hu, Warren J. Leonard, Edwin C. K. Wan. Tetramerization of STAT5 promotes autoimmune-mediated neuroinflammation. Proceedings of the National Academy of Sciences, 2021; 118 (52) DOI: 10.1073/pnas.2116256118 … Read more

New discovery may help reduce side effects of multiple sclerosis drugs

Journal Reference: Shian Liu, Navid Paknejad, Lan Zhu, Yasuyuki Kihara, Manisha Ray, Jerold Chun, Wei Liu, Richard K. Hite, Xin-Yun Huang. Differential activation mechanisms of lipid GPCRs by lysophosphatidic acid and sphingosine 1-phosphate. Nature Communications, 2022; 13 (1) DOI: 10.1038/s41467-022-28417-2 The study, published Feb. 8 in Nature Communications, details the precise molecular structure of the … Read more

Harvard researchers: Multiple sclerosis is a late sequel to a viral infection

Harvard researchers Multiple sclerosis is a late sequel to a scaled

RTL> January 14, 2022 – 10:30 am Clock The Epstein-Barr herpes virus has long been suspected of being one of the main triggers for the autoimmune disease multiple sclerosis. Now a new study from the USA provides more solid evidence for this research thesis. The scientific community is enthusiastic, multiple sclerosis experts from Germany describe … Read more